Telangana Aims for Top 5 Global Life Sciences Hub, Targets $25B Investment

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Telangana Aims for Top 5 Global Life Sciences Hub, Targets $25B Investment
Overview

Telangana has launched its new life sciences policy for 2026-30, aiming to become one of the top five global clusters by 2030. The state plans to attract approximately $25 billion in investments and create over five lakh high-quality jobs. This policy marks a strategic shift towards value-led, innovation-powered growth, solidifying Hyderabad's position as a vital hub in the global life sciences value chain.

Global Ambition

Telangana aims to catapult itself into the top five global life sciences clusters by 2030, backed by an ambitious plan to attract $25 billion in investments and create over five lakh high-quality jobs. The 'nextgen' policy, unveiled at the World Economic Forum in Davos, signals a decisive shift from scale-driven manufacturing to value-led, innovation-powered growth. This strategic pivot seeks to position Telangana as a globally integrated hub for discovery, development, and deployment in healthcare and advanced therapeutics.

Investment & Job Targets

The policy targets a significant inflow of capital, aiming for Rs 2 Lakh crore (approximately $25 billion) over the next five years, a substantial increase from the Rs 73,000 crore attracted in the past two years. Simultaneously, the state projects the creation of over 500,000 skilled positions, bolstering its economy and attracting talent.

Policy Pillars

This new framework focuses on fostering frontier research and development (R&D), advanced manufacturing, and global value and innovation centers. Key areas include scaling up the pharmaceutical services ecosystem, diagnostics, medical electronics, precision medicine, and personalized therapies. The government also aims to recognize R&D units as full-fledged industrial enterprises, granting them equal access to incentives to spur scientific innovation.

Infrastructure Boost

Implementation will leverage globally benchmarked infrastructure, including the Green Pharma City, ten pharma villages, expansion of Genome Valley, and enhancement of the Medical Devices Park. These facilities are designed to support integrated operations and attract global players.

Workforce Development

A dynamic and future-ready workforce is central to the strategy. Initiatives include the Telangana School of Life Sciences, industry-aligned curricula, structured internships, and lifelong learning pathways in critical domains such as biologics, AI, bioinformatics, and Health Outcomes and Economic Research (HOER).

Funding Ecosystem

To support this growth, Telangana will establish a dedicated Life Sciences Innovation Fund with an initial corpus of Rs 100 crore ($12 million), scalable to Rs 1,000 crore ($111 million). This public-private partnership model, involving venture capital and private equity, will back startups, scale-ups, and translational research.

Streamlined Operations

The policy emphasizes regulatory streamlining through the TG-iPASS single-window system, offering time-bound and deemed approvals. It also permits 24x7 operations in designated parks, subject to safety norms, and establishes dedicated committees to simplify state-level clearances. Chief Minister A Revanth Reddy stated, "We are building one of the world's most trusted and transformational biosciences ecosystems—driving global health impact from Telangana." The policy's global unveiling at Davos underscores Telangana's conviction that future growth will stem from cross-border collaboration, global capital, and shared innovation agendas.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.